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Abstract 
A prospective community study in a highly malaria endemic area of Papua New Guinea found that infec- 
tion with multiple Plasmodium falciparum genotypes was an indicator of lowered risk of subsequent clinical 
attack. The results suggest that concurrent or very recent infections provide protection from superinfect- 
ing parasites. The finding of an association between reduced risk of clinical malaria and infection with 
parasites of merozoite surface protein 1 (MS&l) type R033 or MSP-2 type 3D7 further suggests that the 
concomitant immunity is, at least in part, a consequence of a response to these major merozoite surface 
proteins. 
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Introduction 
Acute attacks of Plasmodium falciparum malaria in 
partially immune individuals living in areas where ma- 
laria is highly endemic are probably associated with the 
acquisition of new infections (LINES & ARMSTRONG, 
1992; MJZRCEREAU-PUIJALON, 1996), possibly of novel 
variant antigenic type (GUPTA et al., 1994). However, 
many I? falciparum infections fail to produce acute 
symptoms, even in age groups most vulnerable to clini- 
cal attacks (GREENWOOD et al., 1987). 
Recent studies have found differences between the 
parasitological picture in children with asymptomaticP 
falciparum infections and that in clinical malaria patients 
from the same highly endemic areas (ENGELBRECHT et 
al., 1995; CONTAMIN et al., 1996; BECK et al., 1997). 
Surprisingly, instead of a raised frequency of multiple 
infections during clinical episodes, these studies have all 
found the converse. The multiplicity of infection is high- 
er in asymptomatic individuals. For example, in one of 
these studies (ENGELBRECHT et al., 1995) it was found 
that the relative risk of clinical malaria varied depending 
unon whether the merozoite surface nrotein 2 (MSP-2) 
antigens of the infecting parasites belonged to the FC27 
or 3D7 allelic families. 
The reduced frequency of multiple infections in clin- 
ical cases has been considered to indicate a protective ef- 
fect associated with antigenic cross-reaction between 
new inocula and the existing population of parasites cir- 
culating within the individual (EBCK et al., 1997). How- 
ever, the assignment of causality in comparative studies 
with concurrent controls is problematic and it has not 
been possible to exclude the possibility that reduced 
multiplicity of infection is a consequence of, rather than 
a risk factor for, clinical malaria. Stronger evidence for 
causality in epidemiological studies is provided when 
the temporal order of events is recorded (BRADFORD- 
HILL, 1965). It is therefore useful to know whether mul- 
tiple infections in asymptomatic individuals in a com- 
munity survey are followed by periods of reduced risk of 
clinical attacks. 
We report here a prospective study of the risk of clin- 
ical malaria in relation to the multiplicity of infection in 
children living in the same highly endemic area of Papua 
New Guinea as that studied by ENGELEWXHT et al. 
( 1995). Morbidity surveillance was conducted by week- 
ly household visits, thus further complementing the re- 
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sults of the previous studies, which considered only 
morbidity recorded at health facilities. 
Materials and Methods 
Sampling 
A cohort of 236 children aged c 18 years were recruit- 
ed as described by AI-YAMAN et al. (1995). The chil- 
dren were invited-to attend 3 cross-sectional surveys in 
October 1992. March 1993. and Tulv 1993. At each sur- 
vey, venous blood was coll&ted”i&o ethylenediamine- 
tetraacetic acid tubes for parasite typing. 
Morbidity surveillance 
Surveillance for clinical malaria was carried out via 
community-based case detection through weekly visits 
to the children enrolled in the study as described previ- 
ouslv (AI-YAMAN et al.. 1995). Fever was defined as an 
axillaj temperature Z37*5”C,‘or a history of fever in the 
last 3 d. Blood lihns were prepared from all febrile chil- 
dren. Episodes which were detected only by surveillance 
at health facilities were not included in the present anal- 
yses. 
For each child all weekly visits up to and including the 
time of the first clinical episode constituted the total vis- 
its at risk. Each visit was classified accordina to the nar- 
asitological status at the most recent cross-sectional 
survey. Any one child might contribute time at risk sub- 
sequent to-any of the 3 surveys, but we considered only 
the first clinical enisode satisfvina the case definition for 
each child. Twohistinct case d&&ions were used to 
define clinical I? falciparum malaria: (i) an episode of fe- 
ver associated with a blood slide showing asexual stages 
of I? f&par-urn, and (ii) an episode of fever associated 
with a I? falciparum parasitaemia >5OOO/pL. 
Parasitological methods 
Thick and thin blood films prepared in the field were 
air-dried. stained with 4% Giemsa’s stain. and exam- 
ined for malaria parasites; 100 microscopical thick film 
fields were searched before a slide was considered nega- 
tive. All 135 samples from cases in which asexual I? fal- 
cmarum uarasites were detected bv microscopv were 
included‘in the study. These sampies corresponded to 
78% of the microscouicallv nositive slides. We assumed 
that the parasitological pattern in other children with 
positive blood slides from whom samples were not avail- 
able was similar to that in these samples. In order to ob- 
tain unbiased estimates of prevalence and of relative 
risks, we therefore chose at random 356 (78%) of the 
microscopically negative slides for inclusion in data 
analyses. Blood samples with negative slides were not 
genotyped. 
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Polymerase chain reaction typing 
When asexual stages ofl? falciparum were detected in 
blood films, a 10 pL aliquot of the corresponding blood 
sample was lysed. with 90 ~.IL of 8 M g&&line-hydro- 
chloride/O.1 M sodium acetate (oH 4.8). deoxvribonu- 
cleic acid (DNA) was extracted ‘*using’ Magic 
Miniprep=M columns @omega) and an MSP- l/MSP-2 
multiplex polymerase chain reaction (PCR) was per- 
formed, as described previously (REEDER & IMAR- 
SHALL, 1994). This was followed by a second round of 
amplification with nested, individual MSP-1 and MSP- 
2 PCRs to increase sensitivity (AL-YAMAN et al., in 
press). The second round MSP-1 and MSP-2 reactions 
of each sample were pooled, precipitated with ethanol 
and subjected to electrophoresis on 20 cm, 1.2% agar- 
ose gels and visualized by transillumination with ultravi- 
olet light. Fragment sizes were then calculated by 
comparison with appropriate standards and controls. 
Size differences in MSP-1 and MSP-2 fragments were 
used to detect the presence of mixed infections in indi- 
vidual samples. 
After visualizing the fragments, the gels were blotted 
on to nylon membranes (Hybond-WM, Amersham UK) 
which were probed sequentially with radiolabelled 
MSP-1 and MSP-2 family-specific probes by standard 
methods (FOLEY et al., 1992;-A1-Y& et ai, 1997) to 
determine allelic familv tvne. The MSP-1 orobes used 
were MAD20/FC27, l?l*kellcome and 6033, as de- 
scribed by SNEWIN et al. (1991). The MSP-2 probes 
used were FC27 and 3D7, as described by h%&RSHW 
et al. (1994). 
Results 
Parasite DNA was amplified from 135 samples ob- 
tained during the cross-sectional surveys, corresponding 
to 78% of the parasitaemic blood films examined. The 
frequencies of single and multiple bands are given in the 
TaGle. Multiple Gands were more frequent& observed 
when MSP-1 rather than MSP-2 was amolified. In onlv 
3 samples were single infections detected using MSP-1 
but multiple infections using MSP-2; 19 samples pro- 
duced multiple bands using MSP-1 but only single 
bands using MSP-2. It appeared, therefore, that under 
these conditions the MS&l PCR was a more sensitive 
indicator of the presence of multiple clones than the 
MSP-2 reaction. 
The prevalences of single and multiple infections 
identified using MSP-1 amplification are shown accord- 
ing to age in the Figure, A. As in other studies in the 
same area (SMJTH et al., 1994; GENTON et al., 1995a), 
parasite prevalence in children increased over most of 
the age range. The age trend with single infections was 
sirnil& to &at with multiple infections. Similarly, the 
orevalences of individual allelic families of both MSP- 1 
Hnd MSP-2 showed age dependences similar to that of 
the total infections (Figure). 
The incidence of morbidity showed a strong age de- 
pendence similar to that found in previous studies in the 
same area (SMITH et al., 1994; GENTON et al., 1995b). 
Therefore analyses of the risk of clinical malaria in rela- 
tion to parasitological status (Table) were adjusted for 
age effects. 
Similar relationships were found between parasitolog- 
ical status at the cross-sectional surveys and subsequent 
malaria morbidity risk, irrespective of which of the 2 
definitions of clinical malaria was used (Table). Overall, 
fever episodes with patent l? fakipancm parasites were 
detected at 057% of the household visits, and fever with 
I? falciparum densities greater than 5000&L at 0.32% of 
visits. The presence of patent l? falciparum infection in 
general, MSP-2 type FC27 and MSP-1 types MAD20 
or Kl infections in particular, did not affect the risk of 
subsequent clinical episodes. However, MSP-2 type 
3D7 and MSP-1 type R033 parasites were associated 
with a reduction in the risk of subsequent episodes. The 
effect with 3D7 was, however, statistically significant 
only when the more specific case definition for clinical 
malaria was used (fever with >5000 parasites/&). 
When onlv a single infecting clone was detected bv 
PCR, the pr&pect&e risk of clkical malaria was highhr 
than that in children who were not initially parasitaemic 
by microscopy (Table). However, the risk in children 
with multiple infections was much lower than that in ei- 
ther aparasitaemic children or in those with sinele infec- 
tions,-irrespective of whether multiplicity was-assessed 
usine MSP-1 or MSP-2 tvnine. 
A<otal of 33 PCR-po&iTndividuals could be fol- 
lowed at the next cross-sectional survey and parasites 
amplified from their further samples. Of 14 with single 
clone infections at the initial survey, 7 had multiple 
clones detected at the follow-up survey. Four of 19 in- 
dividuals who initially had multiple clones detected had 
Table. Recorded malaria morbidity rates by parasitological status at cross-sectional surveys 
Fever and any patent l? falciparum parasitaemia 
No. of 
Fever and I? falciparum parasites >5000/& 
Parasitological baseline Visits at Episode/ Visits at 
slidesa riskb Episodes 100 visits PC riskb 
Episode/ 
status Episodes 100 visits PC 
$n;na;; (including follow-up 491 of 9800 children with 56 negative 0.57 slides) 10044 37 0.37 
Any parasite 135 2735 :: 0.55 0:98 2820 9 0.32 oT7 
FC27 (MSP-2) 92 1828 0.60 0.9 1873 8 0.43 0.7 
3D7 (MSP-2) 90 1940 6 0.31 0.11 1989 2 0.10 0.017 
MAD20 (MSP-1) 77 1593 0.56 0.9 1638 6 0.37 0.9 
Kl (MSP-1) 90 1895 190 0.53 0.9 1963 0.20 0.2 
R033 (MSP-1) 26 524 0 0.00 0.01 524 : 0.00 0.04 
Analyses (including follow-up of children with PCR positive slides) 
Single (MSP- 1) 66 1224 10 0.82 - 1272 7 0.55 - 
Multiple (MSP-1) 69 1511 1; 0.33 0,042 1548 0.13 0.027 
Single (MSP-2) 82 1555 0.84 - 1631 : 0.49 - 
Multiple (MSP-2) 53 1180 2 o-17 0.009 1189 1 0.08 0.033 
aIn this study 3 cross-sectional baseline surveys were carried out.Thus each child could be observed up to 3 times (when a slide was 
taken). Corresponding to each of these baseline observations was a follow-up period which lasted either until a malaria episode oc- 
curred or until the next survey. The numbers in the Table are the numbers of slides from all of the baseline surveys which were 
followed-up. 
bThe number of weekly visits up to and including the visit at which the first clinical episode was detected. 
CLikelihood x2 ratio test, one degree of f’reeedom in an age-adjusted Poisson regression model testing whether the prospective risk 
of morbidity differed between (i) children with the infection specified and those without that infection in the section including chil- 
dren with negative slides, and (ii) single and multiple infections in the section including children with PCR (polymerase chain 
reaction) positive slides. 
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Figure. Prevalence by age of (A) single and multiple clone infections of Plasmodium fukipurum and (B) MSP-1 (MADZO, Kl, R033) 
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only single clones detected at the follow-up; multiple 
clones were again detected in the other 15 children. 
Discussion 
Previous studies of the genetic diversity of malaria 
parasites in the host as a risk factor for clinical malaria 
have compared malaria patients with control individuals 
from the same community. The design of these studies 
was appropriate for the identification of virulent geno- 
types but it was not optimal for the identification of pro- 
tective factors. The finding that multiple infections were 
less frequent in the clinical cases was unexpected, and 
the hypothesis that a high multiplicity of infections pro- 
tect against clinical attacks caused by superinfections 
could not be proven with this study design. It was not 
clear whether low multiplicity of genotypes, as identified 
by PCR amplification, was a cause or a consequence of 
clinical malaria. 
Malaria patients seeking treatment are likely to be a 
selected group favourably disposed towards the health 
services, and are likely to have been treated more tie- 
quently in the past than other members of the commu- 
nity. This could explain why they are less likely to be 
infected with multiple clones of parasites. In the present 
study we have excluded this potential bias by consider- 
ing only clinical malaria cases detected by household 
visits. 
Clinical malaria in the partially immune child occurs 
when high parasite densities are reached. If, as seems 
likelv, the expansion of a single parasite clone is respon- 
sible for the-symptoms, this-cl&e will provide most of 
the temnlate for the PCR reaction, making it difficult to 
detect 16~ density co-infections. fiere is-also evidence 
that fever itself has an anti-parasitic effect 
(K~L+XTKOWSKI, 1989), and that clinical malaria trig- 
gers a complex cascade of cellular and humoral respons- 
es which also have marked anti-parasitic effects 
(KWIATKOWSKI, 1991). It follows that the pathology of 
malaria may result in a comparable reduction in densi- 
ties of all clones of the parasite, which might well elimi- 
nate low-density clon&. In the study bi BECK et al. 
(1997), these alternatives to the hypothesis of a protec- 
tive effect of multiple infections were dismissed because 
they could not readily explain the absence of the effect 
in children vaccinated with the SPf66 malaria vaccine. 
The results of the present study support the interpre- 
tation that multiple infections are protective. The lower 
incidence of clinical attacks during follow-up of children 
with multiple infections clearly indicated that existing 
infections provided clinical protection against superin- 
fecting parasites. This is not contradicted by the lower 
risk in children with no patent infection compared to 
those with single infecting clones: heterogeneities in ex- 
posure to infective bites within the study area are likely 
to mean that a subset of the children were at relatively 
low risk of both infection and clinical attacks because of 
low exposure. 
The rate of malaria episodes for individuals with neg- 
ative blood slides (058/100 weeks) lay between those 
for individuals with single and multiple infections. This 
was presumably because negative slides reflect lower ex- 
posure. If a subset of individuals were not exposed at all, 
they would obviously have negative initial slides and no 
subsequent malaria morbidity. On the other hand, indi- 
viduals with negative initial slides, as a result of recent 
clearance of infection, but substantial exposure would 
be expected to have high subsequent morbidity. These 
2 groups could not be distinguished in the present anal- 
yses. 
Amplification of closely spaced longitudinal samples 
from the same individuals (DAUBERSIES et al., 1996) 
has shown that, in areas with high rates of transmission, 
there was a rapid turnover of individual parasite popula- 
tions. Although our data on the rates of change between 
single and multiple infections are limited, they do indi- 
cate that individual children do not remain fixed in one 
or the other of these categories. The fact that we could 
demonstrate a significant protective effect associated 
with multiple infections therefore suggests that it is con- 
current or very recent infections which provide clinical 
protection, rather than an immunological response in- 
duced by a long history of high multiplicity infections. 
The finding that the protective effect was specifically 
associated with parasites belonging to the 3D7 (MSP-2) 
allelic family corresponds to the previous results 
ENGELBRECHT et al. (1995), although in that study it 
was not possible to distinguish between a protective ef- 
fect of 3D7 CMSP-2) narasites and enhanced virulence 
of FC27 (MSP-2) p&sites. This finding, together with 
the apparent protective effect of R033 (MSP-1) para- 
sites, encourages the hypothesis that concomitant im- 
munity is a consequence of immune responses against 
polymorphic epitopes of the major merozoite proteins 
themselves, rather than that these alleles simply act as 
markers for multiplicity of infections. 
At the same time, this form of protection is clearly not 
the only mechanism of naturally acquired clinical im- 
munity against l? falciparum. Even in areas of the high- 
est endemicity, the build up of overall clinical immunity 
takes several years, whilst multiple infections can be ac- 
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quired rapidly even after effective antimalarial treatment 
(BECK et al., 1997). The immunity associated with co- 
infecting parasites seems to be an important component 
of the overall battery of protective responses available to 
the partially immune host. 
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